Local low-dose of soluble GM-CSF significantly augments an immune response against tumour antigens in man.
Mellstedt
H
H
Department of Oncology, Karolinska Hospital, Stockholm, Sweden. hme@rah.ks.se
Fagerberg
J
J
Osterborg
A
A
D000276:Adjuvants, Immunologic; D000818:Animals; D019496:Cancer Vaccines / Q000276:immunology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology*; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor